Abstract

Abstract:

The COVID-19 pandemic threw health care logistics and clinical research processes into disarray. This collection of narratives describes the challenges faced by IRB administrators, staff, and committee members as they navigated the SARS-CoV-2 pandemic. The authors transitioned to remote meetings, adjusted to ever-changing information, and untangled the ethical implications of supporting open studies while making room for an influx of new protocols that addressed the pressing public health emergency.

pdf

Share